RxDoctor Payments DataLook up a doctor →

Abigail Terkeltoub

Medical · Raleigh, NCNPI 1891356853

Payments from drug & device makers

$16,036in general payments, 2019–2025

Across 825 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • Lilly USA, LLC$2K
  • Abbott$1K
  • Amgen$684
  • Insulet Corporation$641
  • Xeris Pharmaceuticals, Inc.$584
  • plus $9K from 46 others

What the payments were for

  • Food & beverage$16,036100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,036 in reported general payments places this provider in the 95th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide304$517,271
JardianceEmpagliflozin168$211,776
MounjaroTirzepatide139$209,631
Tresiba Flextouch U-200Insulin Degludec88$144,603
TrulicityDulaglutide56$103,323
FarxigaDapagliflozin Propanediol98$90,530
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog44$78,572
RybelsusSemaglutide46$73,313
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/750$71,613
Tresiba Flextouch U-100Insulin Degludec75$69,989
Fiasp FlextouchInsulin Aspart (Niacinamide)36$52,803
LyumjevInsulin Lispro-Aabc24$47,571
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog52$45,766
Lyumjev Kwikpen U-200Insulin Lispro-Aabc16$41,493
AfrezzaInsulin Regular, Human16$39,520

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Novolog$2,609$599,645365 claims
Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Humalog, Baqsimi$1,801$372,139253 claims
Boehringer IngelheimJardiance, Trijardy Xr, Tradjenta, Synjardy Xr, Glyxambi$509$296,037245 claims
AstraZenecaFarxiga$410$90,53098 claims
MerckJanuvia, Janumet Xr$75$46,54146 claims
Mannkind CorporationAfrezza$437$39,52016 claims
AbbVieSynthroid$487$23,462256 claims
AmgenProlia$684$18,38311 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$157$5,362275 claims
Sanofi-aventis U.S. LLCLantus$324$2,98624 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 878 medical providers in North Carolina.

Other medical in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →